Efficient homing of therapeutic T cells to the brain is a barrier to the success of brain tumour immunotherapy. The authors define how brain tumours regulate immune cell adhesion pathways to endothelial cells to promote immune evasion, and design a homing system to improve T cell trafficking to the brain. Engineering of T cell ligands to optimize adhesion and downstream steps for transmigration shows potential to improve the homing and anti-tumor activity of therapeutic T cells in brain tumours.
- T cells engineered to home in on brain cancer (News & Views p319, doi: 10.1038/d41586-018-05883-7)
- A homing system targets therapeutic T cells to brain cancer (Article p331, doi: 10.1038/s41586-018-0499-y)
Recent Hot Topics
Sign up for Nature Research e-alerts to get the lastest research in your inbox every week.